One of the major areas of focus at ECIO 2025 was breast cancer cryoablation, with ProSense® featuring in seve ICCM reports strong kidney cancer cryoablation study results, showcasing 88.7% ...

About ProSense® The ProSense® Cryoablation System is a minimally ... including breast, kidney, lung, and liver. ProSense® enhances patient and provider value by accelerating recovery, reducing ...

Conclusion: Cryoablation is a safe and effective treatment ... destruction in benign and cancerous lesions, including breast, kidney, lung, and liver. ProSense® enhances patient and provider ...

US-based HistoSonics has secured the first major insurance coverage for its histotripsy system, amid media speculation of a ...

In addition, we recently announced our agreement to acquire SoniVie, which has developed a clinical stage differentiated ultrasound based renal denervation technology. We look forward to closing ...

Cryoablation during lobectomy for lung cancer appears to be a safe and cost-effective strategy for easing postoperative pain, according to a study published in Pain and Therapy. “Cryoablation is ...

Apr. 9, 2025 — Researchers have identified type 5 collagen as a key factor in kidney fibrosis, revealing its potential as a biomarker to predict chronic kidney disease progression. A repurposed ...

Patients with DME who are treated using aflibercept are more likely to experience acute kidney injury or hospitalisation due to renal events than those treated with ranibizumab. Using a target ...